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Letter to the Editor
On cohort effects in studies on oral contraceptive use and
breast cancer
Sir - The letter by Le et al. (1985) described a
strong association between the birth year and the
exposure to oral contraceptives (OC) in young ages.
It was pointed out that if the controls (in a case-
control study) were older than the cases there could
be a false positive result because of the older
women's lower probability of having used OC at an
early age. We agree in principle with this
conclusion but we would like to describe another
more serious effect from the association between
the birth year and the OC-use.
If there exists a causal relationship between
breast cancer and OC-use at a young age then it is
likely that there will be individually varying latency
times between the start of OC-use and the time of
diagnosis of the initiated/promoted tumour. As the
starting age of OC is strongly associated with the
year of birth it follows directly that until all studied
women are dead there will be an association
between the start of OC and the latency times. The
earlier the study is performed, the stronger this
association will be. In a case-control study this will
mean that among the cases the distribution of
exposure to OC in a young age as compared to an
older age will be biased because, due to shorter
latency times for the former group, fewer cases will
be known at the time of the sampling. This will
inevitably lead to an underestimate of the true
relative risk. In fact, in an extreme case not even an
infinite relative risk could have been discovered.
This latency time bias could explain why positive
studies seem to be more frequent the later the date.
Contrary to the cohort effect described by Le et al.,
the latency time effect cannot be totally accounted
for in the design of the study. The only remedy is
to wait.
The positive studies referred to by Le et al. were
all published in the eighties and used data from
geographical areas (e.g. California, UK, Sweden)
where OC can be expected to have been accepted
early by young women.
We thus suggest that apart from serious flaws the
differences in results between studies on oral
contraceptives and breast cancer can be explained
by differences in time lag between the data of the
study and the point of time when a sufficient
prevalence of young OC-users occurred.
Yours etc.
H. Olsson, J. Ranstam, T.R. M6ller,
Department of Oncology,
University Hospital,
S-221 85 Lund, Sweden.
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